Genetic correlation of antisocial behaviour with alcohol, nicotine, and cannabis use by Tielbeek, J.J. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/190837
 
 
 
Please be advised that this information was generated on 2019-06-01 and may be subject to
change.
Contents lists available at ScienceDirect
Drug and Alcohol Dependence
journal homepage: www.elsevier.com/locate/drugalcdep
Short communication
Genetic correlation of antisocial behaviour with alcohol, nicotine, and
cannabis use
Jorim J. Tielbeeka,b,c, Jacqueline M. Vinkd, Tinca J.C. Poldermana,b, Arne Popmac,
Danielle Posthumaa,b, Karin J.H. Verweijd,e,f,⁎
a Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, VU University, De Boelelaan 1085, 1081 HV Amsterdam, The Netherlands
bNeuroscience Campus Amsterdam, VU University, De Boelelaan 1085, 1081 HV Amsterdam, The Netherlands
c Department of Child and Adolescent Psychiatry, VU University Medical Center, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands
d Behavioural Science Institute, Radboud University, Montessorilaan 3, 6525 HR Nijmegen, The Netherlands
e Department of Biological Psychology/Netherlands Twin Register, VU University, van der Boechorststraat 1, 1081 BT Amsterdam, The Netherlands
fDepartment of Psychiatry, Amsterdam Medical Center, University of Amsterdam, Meibergdreef 5, 1105 AZ Amsterdam, The Netherlands
A R T I C L E I N F O
Keywords:
Cannabis
Nicotine
Cigarette
Alcohol
Antisocial behaviour
Genetic correlation
Substance
A B S T R A C T
Background: There is high comorbidity between antisocial behaviour (ASB) and substance use, and twin studies
have shown that part of the covariation is due to overlapping genetic inﬂuences. Here we used measured genetic
eﬀects to estimate the genetic correlations of ASB with nicotine, alcohol, and cannabis use.
Methods: We meta-analysed data from two genome-wide association studies for ASB and used existing summary
statistics from the largest genome-wide association studies into substance use (ever smoking, cigarettes smoked
per day, weekly alcohol consumption, and lifetime cannabis use). We performed cross-trait LD-score regression
to estimate genetic correlations between ASB and substance use phenotypes explained by all single nucleotide
polymorphisms (SNPs). When signiﬁcant, we tested whether the signs of the regression coeﬃcients of SNPs from
the ASB and substance use phenotypes were in the same direction across multiple p-value thresholds and ex-
amined enrichment in overlap of the strongest associated SNPs.
Results: We found nominally signiﬁcant genetic correlations of ASB with lifetime cannabis use (rg= 0.69,
p=.016) and cigarettes per day (rg= 0.59, p=0.036) but not with weekly alcohol consumption or ever
smoking. Sign-tests revealed consistent directions of eﬀect of SNPs for ASB and cannabis use for all p-value
thresholds except the most stringent one, whereas for ASB with cigarettes per day no consistent evidence was
found. We found no evidence of enrichment in overlap of the most associated SNPs across these traits.
Conclusion: Using measured genetic variants, we found preliminary support for a genetic correlation of ASB with
lifetime cannabis use and cigarettes per day.
1. Introduction
Antisocial behaviours (ASBs, including conduct problems and anti-
social personality) are characterised by irresponsible, impulsive, ag-
gressive, and dishonest behaviours and pose a major burden on aﬀected
individuals and their families as well as on society as a whole (Foster
and Jones, 2005; McCollister et al., 2010). The consequences of
ASB—particularly violent behaviour—are severe and can be long
lasting.
ASBs show substantial comorbidity with other psychiatric syn-
dromes and maladaptive behaviours (Abram et al., 2015). Previous
studies have shown that individuals with antisocial personality or
conduct problems are at increased risk for substance (ab)use, including
nicotine, alcohol, and cannabis use (e.g., Compton et al., 2005; Elkins
et al., 2007; Fergusson et al., 2007; Goldstein et al., 2017; Palmer et al.,
2013). In a 25-year longitudinal study, Fergusson et al. (2007) found
that conduct problems during childhood and adolescence are related to
later nicotine, alcohol, cannabis, and illicit drug use, abuse, and de-
pendence (with the exception of alcohol use, probably as a result of the
high rate of alcohol use in the cohort). The eﬀects remained even after
controlling for attentional problems and confounding social, family,
and related factors (individual characteristics and behaviours).
Twin and family studies have shown that antisocial behaviours and
substance use are heritable traits. Heritability estimates for conduct
symptoms and conduct disorder generally range between 40% and 60%
(Gelhorn et al., 2005; Miles et al., 2002; Polderman et al., 2015; Rhee
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and Waldman, 2002; Verweij et al., 2016), and a meta-analysis of be-
havioural genetic studies of antisocial behaviour indicates that genetic
factors explain 56% of the variance in antisocial personality and be-
haviour (Ferguson, 2010). For alcohol consumption, heritability esti-
mates are approximately 40–60% (Heath and Martin, 1994; Kendler
et al., 2008; Verweij et al., 2016). A meta-analysis of twin studies es-
timated the heritability of smoking initiation to be 37% for males and
55% for females and the heritability of smoking persistence to be 59%
for males and 46% for females (Li et al., 2003). A meta-analysis of twin
studies into lifetime cannabis use estimated the heritability at 48% for
males and 40% for females (Verweij et al., 2010).
Results from twin studies further show that the relationship be-
tween ASB and substance use is in part due to overlapping genetic in-
ﬂuences (Grant et al., 2015; Malone et al., 2004; Miles et al., 2002;
Shelton et al., 2007; Verweij et al., 2016), suggesting there may be
common biological mechanisms underlying these behaviours. Neu-
roscientiﬁc studies have indeed shown the presence of brain impair-
ments related to cognitive control, impulsivity, and reward sensitivity
in both ASB and substance abuse disorders, suggesting common etio-
logical pathways underlying these traits (Hyde et al., 2013; Iacono
et al., 2008; Raine, 2008; US DHHS, 2016).
With methodological advances in molecular genetics and increased
sample sizes in genome-wide association studies (GWASs), it has be-
come viable to use measured genetic variation among individuals to
examine the genetic relationship between antisocial behaviour and
substance use. Here, we estimated the genome-wide genetic correlation
between antisocial behaviour and substance use phenotypes.
2. Methods
We employed (cross-trait) LD-score regression (Bulik-Sullivan et al.,
2015) to estimate the SNP heritability and the genetic correlation be-
tween ASB and substance use phenotypes that could be explained by all
SNPs. Brieﬂy, LD-score regression is based on the fact that an estimated
SNP eﬀect-size incorporates eﬀects of all SNPs in LD with that SNP.
SNPs that tag more genetic variation will have a higher probability of
tagging a causal variant; therefore, SNPs with higher LD have on
average a higher χ2 statistic than SNPs with lower LD. When regressing
the χ2 statistics as obtained from a GWAS against the LD score for each
SNP, the slope of the corresponding regression line provides an estimate
of the proportion of trait variance accounted for by all genotyped SNPs
(Bulik-Sullivan et al., 2015). Cross-trait LD-score regression is an ex-
tension in which the genetic covariation between traits is estimated
using GWAS summary statistics of these traits (Bulik-Sullivan et al.,
2015). The genetic covariance is estimated using the slope from the
regression of the product of z-scores from the GWASs on the LD score.
The estimate represents the genetic correlation between the two traits
based on all polygenic eﬀects captured by all SNPs.
Here, we estimated the genetic correlation of ASB with alcohol,
nicotine, and cannabis use by capitalizing on large GWAS meta-ana-
lyses available. For substance use, summary statistics were obtained for
four phenotypes from the three largest published GWASs to date (see
Supplementary Table 1): ever smoking (≥100 cigarettes) and cigarettes
per day (Tobacco and Genetics Consortium, 2010), weekly alcohol
consumption (Clarke et al., 2017), and lifetime cannabis use (Stringer
et al., 2016).
For ASB we performed a GWAS meta-analysis in order to obtain a
larger GWAS sample. We meta-analysed summary data from the pub-
licly available EAGLE consortium (N=18,988, Pappa et al., 2016) with
those from non-overlapping samples of the Broad Antisocial Behavior
Consortium (Tielbeek et al., 2017), totalling 31,968 participants. To
maximize sample size, we included studies with a broad range of an-
tisocial measures, including both aggressive and non-aggressive do-
mains of antisocial behaviour, and utilized study-speciﬁc scales in dif-
ferent age groups (details are provided elsewhere, see Pappa et al.,
2016; Tielbeek et al., 2017). The meta-analysis was run using a ﬁxed-
eﬀects model with z-scores weighted by sample size as implemented in
the software METAL (Willer et al., 2010). We only utilized the results of
polymorphisms with a combined sample size greater than 20,000.
From the cannabis, alcohol, and nicotine GWAS summary statistics,
only SNPs present in all contributing cohorts were included.
Furthermore, we only included HapMap-3 SNPs (as recommended by
Bulik-Sullivan et al., 2015), resulting in 968,384, 911,020 and 967,376
SNPs for nicotine, alcohol, and cannabis use, respectively. Analyses
were performed with the LDSC software package using pre-calculated
LD scores (Finucane et al., 2015).
We performed additional (follow-up) analyses for those substance
use traits for which we found a nominally signiﬁcant (p< 0.05) ge-
netic correlation with ASB. We clumped the SNPs in PLINK to identify a
smaller set of independent SNPs (using 1000 Genomes V3 for
Europeans as reference panel, 0.1 as LD r2 threshold, and 500 KB as
physical distance threshold). First, we tested whether the signs of the
regression coeﬃcients of the SNPs for ASB and the substance use phe-
notypes were, more often than expected by chance, in the same direc-
tion using a binomial test to verify whether the proportion of SNPs with
concordant sign was higher or lower than expected by chance (0.5).
Secondly, we tested whether there was signiﬁcant overlap in associated
SNPs for ASB and substance use phenotypes for diﬀerent p-value bins
using Fisher exact tests. Brieﬂy, we computed 2×2 contingency tables
and then tested for homogeneity of proportion by computing an odds
ratio through comparison of the binomial probabilities of enrichment of
low p-values in same SNPs versus no enrichment.
3. Results
First, the SNP-based heritability estimates of and the genetic cor-
relations between ASB and the substance use phenotypes were calcu-
lated (see Table 1). The estimated proportion of the phenotypic var-
iance in ASB explained by all SNPs was 2.9% with a standard error of
1.5% (p= .0.06), which is very low. We found nominally signiﬁcant
(α < 0.05) genetic correlations of ASB with lifetime cannabis use
(rg= 0.69, p=0.016) and with cigarettes smoked per day (rg= 0.59,
p= .036) but not with alcohol consumption or ever smoking
(rg=−0.06, p= .047; rg= 0.24, p= .019, respectively).
3.1. Follow-up analyses
The sign-tests revealed consistent directions of eﬀect for SNPs in
ASB and lifetime cannabis use for three p-value thresholds (proportions
were 0.53, 0.56, and 0.62 for p-value thresholds 1, 0.05, and 0.001,
respectively) but not for the most stringent threshold of 0.0001. These
Table 1
Estimates of the SNP-based heritability and the genetic correlations (rg) be-
tween ASB and four substance use phenotypes.
SNP-based heritability Genetic correlation
with ASB
Phenotype Sample size h2SNPs
(SE)
P-value rg (SE) P-value
Antisocial
Behaviour
(ASB)
31,968 0.029
(0.015)
0.060 – –
Weekly alcohol
Consumption
112,117 0.079
(0.006)
< 0.0001 0.26
(0.21)
0.225
Cannabis use
(lifetime)
32,330 0.091
(0.016)
< 0.0001 0.69
(0.29)
0.016*
Smoking (ever use) 74,035 0.077
(0.007)
< 0.0001 0.24
(0.19)
0.191
Smoking (cigarettes
per day)
38,181 0.057
(0.014)
< 0.0001 0.59
(0.28)
0.036*
* Signiﬁcant at α < 0.05; SNP h2: narrow-sense heritability based on all
SNPs; rg: genetic correlation with ASB.
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results further support the ﬁnding of genetic overlap between the two
traits. The sign-tests for ASB and cigarettes per day showed no con-
sistent directions of eﬀect (proportions were 0.50, 0.50, 0.50, and 0.58
respectively) for SNPs selected for diﬀerent p-value thresholds (1, 0.05,
0.001 and 0.0001). Moreover, Fisher exact tests showed no evidence for
enrichment of SNPs with low p-values across the genetically over-
lapping traits, regardless of sign, which indicates that the genetic cov-
ariance is not due to SNPs with low p-values in both samples but to
more subtle eﬀects of a large sample of SNPs with the same direction of
eﬀect (see Table 2 for full results of the follow-up analyses).
4. Discussion
Using measured gene eﬀects, we found nominally signiﬁcant genetic
correlations of ASB with lifetime cannabis use and cigarettes smoked
per day but not with alcohol consumption and ever smoking. The ge-
netic correlations of ASB with cannabis use and cigarettes smoked per
day were substantial (rg= 0.69, p=0.016 and rg= 0.59, p=0.036,
respectively), indicating a considerable overlap in the genetic inﬂu-
ences on ASB and those on cannabis use and cigarettes per day.
Findings for the genetic correlation between ASB and cannabis use were
further supported by the sign test demonstrating the same direction of
eﬀect for SNPs in most p-value bins for ASB and cannabis use but not for
ASB and cigarettes smoked per day.
The genetic correlations of ASB with alcohol consumption and ever
smoking were much lower and not signiﬁcantly diﬀerent from zero. A
potential explanation for higher correlations of ASB with cannabis use
and cigarettes per day compared to ever smoking and alcohol use may
be that cannabis use and smoking (many) cigarettes per day are more
deviant phenotypes than alcohol consumption (Orlando et al., 2005)
(which is generally accepted in Western societies) and ever smoking
which includes experimenting only. If these traits represent more de-
viant behaviours, they may be more strongly (genetically) related to
antisocial behaviour. In line with this hypothesis, two previous twin
studies reported a weaker relationship between ASB/conduct and al-
cohol (ab)use than between ASB and nicotine or cannabis use
(Fergusson et al., 2007; Verweij et al., 2016). Moreover, in another twin
study, Grant et al. (2015) found a lower genetic correlation between
conduct disorder and alcohol dependence than between conduct dis-
order and nicotine or cannabis dependence, whereas the phenotypic
correlations were in the same range. On the contrary, Verweij et al.
(2016) found in their twin study that the correlation between conduct
symptoms and alcohol use was almost completely explained by over-
lapping genetic inﬂuences.
Notwithstanding the high genetic correlations, it is important to
realize that the SNP-based heritability estimates, on which these results
were based, were rather low and ranged from 2.8% for ASB to 9.1% for
cannabis use. In particular, the SNP-based heritability for ASB is very
low, indicating that—based on these GWAS results— SNPs can only
explain a very small proportion of the individual diﬀerences in ASB. As
a consequence, although the genetic correlations of ASB with cannabis
use and cigarettes per day were substantial, in absolute terms the ge-
netic variance that is overlapping between the two traits is relatively
low.
A general limitation of these analyses is that they are heavily de-
pendent upon the size of the GWAS samples; larger samples provide
more power to accurately estimate the SNP eﬀect sizes. For ASB and
cannabis use, the sample sizes were relatively small for this type of
analyses, and both meta-analyses were based on data from very het-
erogeneous cohorts (see Supplementary Table S1) which could lead to
less accurate SNP eﬀects and hence a lower SNP-based heritability. On
the other hand, we did ﬁnd a signiﬁcant genetic correlation between
these two phenotypes, suggesting the power was suﬃcient to detect
such eﬀects. It should also be noted that a genetic correlation does not
imply that the same genes underlie both phenotypes (genetic pleio-
tropy), but rather that it could also be due to a causal relationship
between the two phenotypes.
Overall, our study provides some support for a correlation of ASB
with lifetime cannabis use and cigarettes per day on a genetic level.
Future studies with advanced technologies, novel statistical approaches
(such as Mendelian randomisation), and larger sample sizes should aim
to determine the nature of the genetic association between ASB and
substance use and identify common genes and biological mechanisms
that can explain the genetic association.
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Table 2
Sign and Fisher’s exact test of SNP eﬀects between 1) ASB and cannabis use and
2) ASB and cigarettes per day for diﬀerent p-value thresholds.
Sign-test Fisher’s exact test
Phenotypes P Threshold Proportion** P-value Odds
Ratio
P-value
ASB −
Cannabis*
1 0.53 <2.2×10−16
ASB −
Cannabis*
0.05 0.56 <2.2×10−16 0.91 0.11
ASB −
Cannabis*
0.001 0.62 9.7×10−7 0.68 0.13
ASB −
Cannabis*
0.0001 0.58 0.13 NA NA
ASB − CPD* 1 0.50 0.03
ASB − CPD* 0.05 0.50 0.26 0.97 0.42
ASB − CPD* 0.001 0.50 0.55 NA NA
ASB − CPD* 0.0001 0.58 0.11 NA NA
* Clumped SNPs.
** The expected proportion under the null hypothesis is 0.5.
CPD= cigarettes per day; NA: too few SNPs were available to perform this test.
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